Charles Macaluso's most recent trade in Lifecore Biomedical Inc was a trade of 5,501 Common Stock done at an average price of $10.4 . Disclosure was reported to the exchange on Oct. 15, 2020.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Lifecore Biomedical Inc | Charles Macaluso | Director | Grant, award, or other acquisition of securities at price $ 10.36 per share. | 15 Oct 2020 | 5,501 | 5,501 (0%) | 0% | 10.4 | 56,990 | Common Stock |
Lifecore Biomedical Inc | Charles Macaluso | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Oct 2020 | 5,501 | 0 | - | - | Restricted Stock Unit | |
Lifecore Biomedical Inc | Charles Macaluso | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2020 | 8,303 | 8,303 | - | - | Right to Buy Restricted Stock Unit (RSU) | |
Darling Ingredients Inc | Charles Macaluso | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 May 2020 | 5,363 | 98,115 (0%) | 0% | 0 | Common Stock | |
Pilgrim`s Pride Corp. | Charles Macaluso | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Apr 2020 | 2,726 | 7,746 (0%) | 0% | 0 | Common Stock, par value $0.01 per share |